GlaxoSmithKline, which is the focus of an ongoing bribery investigation in China, Has named Herve Gisserot to replace Mark Reilly as general manager in China. "He's effective immediately head of the China business, and this is part of our attempt to strengthen our China management team and ensure we can support our customers in China, as well as with the ongoing investigation," a company spokesman said.

Related Summaries